Company Information
Ask for more detail from the seller
Contact SupplierAprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, including high-dose cisplatin.
Aprepitant is for the treatment of adult patients with chemotherapy induced nausea and vomiting.
ADDITIONAL INFORMATION
Aprepitant is given for 3 days as part of a regimen that includes a corticosteroid and a 5-HT3 antagonist. The recommended dose of Aprepitant is 125 mg orally 1 hour prior to chemotherapy treatment (Day 1) and 80 mg once daily in the morning on Days 2 and 3.
SIDE EFFECTS
Call your doctor at once if you have a serious side effect such as:
Less serious side effects may include: